Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT
- Status
- RECRUITING
- Phase
- PHASE1
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC
- Status
- UNKNOWN
- Phase
- N/A
A National Phase II Study of Proton Therapy in Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study
- Status
- UNKNOWN
- Phase
- N/A
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
- Status
- RECRUITING
- Phase
- PHASE3
A Single Center Real-world Study of Donafenib in the Treatment of Hepatocellular Carcinoma in Routine Clinical Practice
- Status
- UNKNOWN
- Phase
- N/A
Multi-analyte Blood Test Clinical Trial
- Status
- RECRUITING
- Phase
- N/A
Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy
- Status
- COMPLETED
- Phase
- N/A
Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or Less
- Status
- COMPLETED
- Phase
- N/A
Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1